Results 71 to 80 of about 1,018 (169)
TAFRO Syndrome in Caucasians: A Case Report and Review of the Literature
Frontiers in Medicine, 2017 BackgroundTAFRO syndrome has been reported in Japan among human herpesvirus 8 (HHV-8)-negative/idiopathic multicentric Castleman’s disease (iMCD) patients.
Céline Louis +8 more
doaj +1 more source
Expert Perspective: Diagnosis and Treatment of Castleman Disease
Arthritis &Rheumatology, Volume 78, Issue 1, Page 12-25, January 2026.Castleman disease (CD) is a major diagnostic challenge for rheumatologists. Unicentric CD (UCD) involves one enlarged lymph node region, whereas multicentric CD (MCD) involves multiple enlarged lymph node regions. Both UCD and MCD may exhibit a wide range of symptoms that overlap with other immune‐mediated conditions.
Luke Y. C. Chen +2 more
wiley +1 more source
Chronic Myelomonocytic Leukemia Associated With TAFRO Syndrome-Like Symptoms
Annals of Internal Medicine: Clinical CasesThrombocytopenia, anasarca, fever, reticulin fibrosis, renal dysfunction, and organomegaly (TAFRO) syndrome is a recent disease concept whose physiopathology remains largely unknown.
Issam Drici-Tani +8 more
doaj +1 more source
Journal of Cancer Research and Practice, 2023 TAFRO syndrome, or now formally termed idiopathic multicentric Castleman disease (iMCD) with thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly (iMCD-TAFRO), describes a unique subtype of iMCD.
Pei-An Fu, Chia-Chi Wu, Ya-Ting Hsu
doaj +1 more source
Lymphadenopathy in the rheumatology practice: a pragmatic approach [PDF]
, 2023 Lymphadenopathy is a common clinical finding and diagnostic challenge within general medicine and rheumatology practice. It may represent a primary manifestation of an underlying immune-mediated disease or indicate an infectious or neoplastic ...
Bongiovanni, Lucia +5 more
core
Thalidomide for tocilizumab‐resistant ascites with TAFRO syndrome
Clinical Case Reports, 2015 Key Clinical MessageTAFRO syndrome have been proposed as a rare variant of Castleman's disease. This article reports a case of a 56‐year‐old man with TAFRO syndrome who was successfully treated with thalidomide in spite of the refractoriness to prednisolone and tocilizumab. Thalidomide may be one of the treatment options for TAFRO syndrome.
Tatekawa, Shotaro +6 more
openaire +2 more sources
The Journal of Dermatology, Volume 53, Issue 1, Page 41-53, January 2026.ABSTRACT Systemic sclerosis is an autoimmune disease characterized by vasculopathy, fibrosis, and immune dysregulation. Anti‐SS‐A antibodies (anti‐SSA) have been reported to confer severe clinical manifestations in some Western and Japanese cohorts. We aimed to determine whether anti‐SSA seropositivity affects clinical outcomes in Japanese patients. We
Nana Ishida +4 more
wiley +1 more source
Journal of Medical Case Reports, 2018 Background TAFRO syndrome, which was first reported in 2010 in Japan, is a relatively rare disease characterized by thrombocytopenia, anasarca, fever, renal impairment, reticulin fibrosis, and organomegaly.
Yu Fujiwara +3 more
doaj +1 more source
TAFRO Syndrome in a Patient of South-American Descent [PDF]
, 2015 A 31-year-old Caucasian woman of South-American descent was diagnosed with a variant of multicentric Castleman disease (MCD) that has been reported in Japan as Castleman-Kojima disease.
Cabral, Cecilia +8 more
core +3 more sources
Autoimmune complications in hematologic neoplasms [PDF]
, 2021 Autoimmune cytopenias (AICy) and autoimmune diseases (AID) can complicate both lymphoid and myeloid neoplasms, and often represent a diagnostic and therapeutic challenge. While autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP) are well
Barcellini W. +2 more
core +1 more source